HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLCs registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HGH Import Alert Grows From 4 Products To 32 In 8 Months

This article was originally published in The Rose Sheet

Executive Summary

An April 18 alert update about a Chinese firm distributing HGH-containing supplements follows the launch of the alert in September and an update in November about other firms in the country reported as shipping supplements tainted with the ingredient.

You may also be interested in...



Grassley’s Swing At Illegal Anabolic Steroid Use Unfairly Strikes DHEA – CRN

Legislation introduced in response to a report on steroid use in Major League Baseball that would put an age restriction on sales of performance-enhancing drugs and supplements - including DHEA - is a "misdirected attempt ... based on emotional rhetoric" to curb illegal anabolic steroid use, industry leaders say

FDA Combines Supplement GMP Recordkeeping, Testing Waiver Estimates

FDA didn't change its estimates for industry's annual regulatory burden – 929,140 hours – from compliance with recordkeeping requirements in supplement GMPs, its estimates of eight hours needed to prepare a request for exemption from identity-testing requirement also in unchanged.

On CRN Challenge, Nexus Formulas Gets Lesson On Supporting Ad Claims For Supplements

So full of errors were the firm's online ads for its Plavinol supplement, the National Advertising Division noted support for some claims contained "many of the same flaws" as others. The prevalence of problems prompted NAD to go outside its "scope of review" and note unclear instructions on Plavinol labels.

Topics

UsernamePublicRestriction

Register

RS109212

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel